H‐2Kb TRANSFECTION OF B16 MELANOMA CELLS RESULTS IN REDUCED TUMOURIGENICITY AND METASTATIC COMPETENCE
- 1 August 1989
- journal article
- research article
- Published by Wiley in International Journal of Immunogenetics
- Vol. 16 (4-5) , 291-303
- https://doi.org/10.1111/j.1744-313x.1989.tb00475.x
Abstract
SUMMARY: The metastatic B16 mouse melanoma shows a low cell surface expression of H‐2Kb and H‐2Db class I antigens on cells of both the high‐metastatic line B16‐F10 and the low‐metastatic line B16‐F1. Similarly, newly generated clones of these lines, having different metastatic properties, all express low levels of major histo‐compatibility antigens. One of these clones, the high‐metastatic F10.9, was transfected with H‐2Kb genes to generate H‐2Kb‐expressing transfectants. The resulting clones showed reduced tumourigenicity and a low metastatic phenotype. Unlike the parental cells, H‐2Kb‐positive transfectants are potent inducers and sensitive targets of H‐2Kb‐restricted syngeneic cytotoxic T cells. Immunization of mice with H‐2Kb‐positive transfectants conferred protection against a subsequent challenge with Kb‐positive transfectants but had only a small effect on growth and metastatic spread of parental cells.This publication has 28 references indexed in Scilit:
- Defective expression of MHC class I antigens is frequent in B‐cell lymphomas of high‐grade malignancyInternational Journal of Cancer, 1987
- Histocompatibility Antigens on Murine TumorsScience, 1985
- Abrogation of metastatic properties of tumour cells by de novo expression of H–2K antigens following H–2 gene transfectionNature, 1985
- Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.The Journal of Experimental Medicine, 1985
- Reversal of Oncogenesis by the Expression of a Major Histocompatibility Complex Class I GeneScience, 1985
- Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformationNature, 1984
- The differential expression of H‐2K versus H‐2D antigens, distinguishing high‐ metastatic from low‐ metastatic clones, is correlated with the immunogenic properties of the tumor cellsInternational Journal of Cancer, 1984
- Interferon, β-2-microglobulin and immunoselection in the pathway to malignancy: A blinkered view from Nag's Head YardImmunology Today, 1983
- Quantitation of basement membrane collagen degradation by living tumor cells in vitroCancer Letters, 1980
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979